Age-associated Neurological Diseases

1. Front Matter

   Pages I-VIII

   PDF

2. Diagnosis, assessment and treatment of age-associated memory impairment

   • T. H. Crook III, G. J. Larrabee

   Pages 1-6

3. Physiology of short-term verbal memory

   • A. Starr, H. Pratt, H. Michalewski, J. Patterson, G. Barrett, F. Swire et al.

   Pages 7-12

4. Positron emission tomography in the differential diagnosis of organic dementias

   • W.-D. Heiss, J. Kessler, B. Szelies, M. Grond, G. Fink, K. Herholz

   Pages 13-19

5. The spectrum of subcortical lesions in MRI, sensitivity and specificity

   • M. Forsting, W. Hacke, K. Sartor

   Pages 21-26

6. Cytoskeleton pathology in Alzheimer’s disease and related disorders

   • F. Seitelberger, H. Lassmann, C. Bancher

   Pages 27-33

7. Morphometry of the corpus callosum in normal aging and Alzheimer’s disease

   • S. Weis, K. Jellinger, E. Wenger

   Pages 35-38

8. Clinical and epidemiological aspects of dementia in the elderly

   • P. Fischer, P. Berner

   Pages 39-48

9. Multiinfarct dementia

   • H. Lechner, G. Bertha

   Pages 49-52

10. Early diagnosis of Alzheimer dementia?

    • C. Lind, M. Mraz, C. Wöber, I. Marschall, L. Deecke, P. Dal-Bianco

    Pages 53-58

11. Galanthamine treatment in Alzheimer’s disease

    • P. Dal-Bianco, J. Maly, Ch. Wöber, C. Lind, G. Koch, J. Hufgard et al.

    Pages 59-63

12. Human blood platelet as research tool in neuropsychopharmacology

    • P. Bongioanni, F. Dadone, M. Donato

    Pages 65-71

13. Pattern electroretinogram and luminance electroretinogram in Alzheimer’s disease

    • K. Strenn, P. Dal-Bianco, H. Weghaupt, G. Koch, C. Vass, I. Gottlob

    Pages 73-80

14. Clinical comparison of dementia in Parkinson’s and Alzheimer’s disease

    • I. Marschall, P. Dal-Bianco, J. Maly, E. Auff, J. Hufgard, M. Mraz et al.

    Pages 81-92

15. Memory dysfunction in Parkinson patients: an analysis of verbal learning processes

    • E. Karamat, J. Ilmberger, W. Poewe, F. Gerstenbrand

    Pages 93-97

16. Does the absence of clinical expression of choreoathetosis, despite severe striatal atrophy, correlate with plasticity of neuropeptide synthesis?

    • S. N. Schiffmann, J.-J. Vanderhaeghen

    Pages 99-103

17. Essential tremor: functional disability vs. subjective impairment

    • E. Auff, A. Doppelbauer, E. Fertl

    Pages 105-110

18. Sympathetic vascular function in patients with central dysautonomia

    • L. Santambrogio, G. Bellomo, M. Mercuri, R. Paltriccia, G. Ciuffetti, E. Mannarino

    Pages 111-114

19. Epidemiology and out-patient care in Parkinson’s disease — Results from a pilot-study in Northern Germany (Schleswig-Holstein)

    • P. Vieregge, J. Kleinhenz, H. Fassl, J. Jörg, D. Kömpf

    Pages 115-118

20. Parkinsonian features in advanced Down’s syndrome

    • P. Vieregge, G. Ziemens, A. Piosinski, M. Freudenberg, D. Kömpf

    Pages 119-124

The papers compiled in this supplementum are a selection of the best con­ th tributions presented at the 19 Central-European Neurological Symposium (CNS 19) held on June 29 - July 1, 1989 in Vienna. The main topic of this conference was degenerative and age-associated neurological diseases. In recent decades life expectancy has dramatically increased, at least in the industrialized countries. This has led to extreme distortions of the so-called population pyramids that no longer look like such but begin to almost resemble cylinders. As a consequence of this "overaging" of the population, diseases that are associated with age have become much more common than before. It was thus more than reasonable to devote a congress of the CNS series to these important neurological diseases. The following fields of interest are covered: Age-associated memory impairment (AAMI), Alzheimer's and other dementias, Parkinson's disease and other movement disorders, stroke and others. Concerning the de men­ tias, some papers deal with diagnosis employing neuro-imaging methods such as MRI, CT, PET and SPECT, others using electrophysiological methods. An important aspect in the early preclinical diagnosis of dementia is the inclusion of neuropsychological tests to enhance the chance of effec­ tive early treatment. Also drugs that are now under clinical investigation are discussed and preliminary results are presented.

• Alzheimer
• PET
• Parkinson
• SPECT
• Syndrom
• alzheimer's disease
• brain
• dementia
• diagnosis
• epidemiology
• magnetic resonance imaging (MRI)
• physiology
• positron emission tomography (PET)
• rehabilitation
• research

• Department of Neurology, University of Vienna, Vienna, Austria

  Lüder Deecke, Peter Dal-Bianco

Policies and ethics